» Articles » PMID: 19595575

Absolute Risk Reductions and Numbers Needed to Treat Can Be Obtained from Adjusted Survival Models for Time-to-event Outcomes

Overview
Publisher Elsevier
Specialty Public Health
Date 2009 Jul 15
PMID 19595575
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cox proportional hazards regression models are frequently used to determine the association between exposure and time-to-event outcomes in both randomized controlled trials and in observational cohort studies. The resultant hazard ratio is a relative measure of effect that provides limited clinical information.

Study Design And Setting: A method is described for deriving absolute reductions in the risk of an event occurring within a given duration of follow-up time from a Cox regression model. The associated number needed to treat can be derived from this quantity. The method involves determining the probability of the outcome occurring within the specified duration of follow-up if each subject in the cohort was treated and if each subject was untreated, based on the covariates in the regression model. These probabilities are then averaged across the study population to determine the average probability of the occurrence of an event within a specific duration of follow-up in the population if all subjects were treated and if all subjects were untreated.

Results: Risk differences and numbers needed to treat.

Conclusions: Absolute measures of treatment effect can be derived in prospective studies when Cox regression is used to adjust for possible imbalance in prognostically important baseline covariates.

Citing Articles

Prescribing methadone in prison predicts linkage to HIV care after release from prison: A randomized and patient preference trial.

Mobley A, Wegman M, Bazazi A, Shenoi S, Bromberg D, Ahmad A Int J Drug Policy. 2025; 137:104733.

PMID: 39923270 PMC: 11875876. DOI: 10.1016/j.drugpo.2025.104733.


Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis.

Aminian A, Aljabri A, Wang S, Bena J, Allende D, Rosen H Nat Med. 2025; .

PMID: 39870816 DOI: 10.1038/s41591-024-03480-y.


Smoking and 10-year risk of cardiovascular and non-cardiovascular events after contemporary coronary stenting.

Kinlay S, Young M, Gagnon D Am J Prev Cardiol. 2024; 19:100718.

PMID: 39247537 PMC: 11380164. DOI: 10.1016/j.ajpc.2024.100718.


Initial clinical evidence on biperiden as antiepileptogenic after traumatic brain injury-a randomized clinical trial.

Foresti M, Garzon E, de Moraes M, Valeriano R, Santiago J, Dos Santos G Front Neurol. 2024; 15:1443982.

PMID: 39175759 PMC: 11339878. DOI: 10.3389/fneur.2024.1443982.


Identification of subgroups within a Japanese older adult population for whom statin therapy is effective in reducing mortality.

Funaki D, Kaneda H, Miyakoshi A, Saito K, Sasaki H, Nakatani E PLoS One. 2023; 18(12):e0295052.

PMID: 38039298 PMC: 10691679. DOI: 10.1371/journal.pone.0295052.